Feng Gao is the lead sponsor of 6 current clinical trials in our China register. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Not applicable. The most-studied condition is Endovascular Treatment.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Randomized Clinical Trial of Endovascular Treatment for Progressive Stroke With Vertebrobasilar Artery Occlusion
NCT07557485 · ClinicalTrials.gov ↗ · Vertebrobasilar Artery Occlusion, Endovascular Treatment
|
Not applicable | Not yet open | 2026-06 | China |
|
Efficacy and Safety of Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Intracranial Atherosclerotic Large Vessel Occlusion (ANGEL-REBOOT 2)
NCT07618052 · ClinicalTrials.gov ↗ · Intracranial Atherosclerotic Stenosis-Related Large Vessel Occlusion, Acute Ischemic Stroke, Bailout Angioplasty or Stenting
|
Not applicable | Not yet open | 2026-06 | China |
|
The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion
NCT07390032 · ClinicalTrials.gov ↗ · Acute Mild Basilar Artery Occlusion, Basilar Artery Occlusion, Endovascular Treatment
|
Not applicable | Not yet open | 2026-03 | China |
|
Randomized Clinical Trial of Endovascular Recanalization for Symptomatic Non-Acute Intracranial Artery Occlusion（REPAIR）
NCT07495969 · ClinicalTrials.gov ↗ · Symptomatic Non-acute Intracranial Artery Occlusion, Ischemic Stroke
|
Not applicable | Not yet open | 2026-04 | China |
|
Efficacy and Safety of Endovascular Thrombectomy in Acute Ischemic Stroke With Posterior Circulation Large Infarct
NCT06924996 · ClinicalTrials.gov ↗ · Acute Basilar Artery Occlusion, Posterior Circulation Large Infarct
|
Observational | By invitation | 2023-01 | China |
|
Relationship Between Serum Vitamin D Levels and Postherpetic Neuralgia.
NCT06232486 · ClinicalTrials.gov ↗ · Postherpetic Neuralgia
|
Observational | Active, closed | 2023-12 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 6 | 0 |
A trial with sites in more than one country appears in each of those registers.
Feng Gao is the lead sponsor of 6 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of its 6 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.